Bit · Neuro

Multiple Sclerosis vs Neuromyelitis Optica vs ADEM

Three central demyelinating diseases that all give optic neuritis, weakness, or both. The pivot is antibody status, lesion distribution, and tempo (relapsing vs monophasic).

Mechanism

All three involve immune-mediated demyelination of CNS white matter. They differ in target antigen and clinical course:

Differentiator Table

Multiple sclerosisNMO spectrum disorderADEM
CourseRelapsing-remitting → secondary progressiveRelapsing, severe attacksMonophasic (rare recurrence)
Typical age20–40, female predominanceAdult, female predominanceChildren, post-viral or post-vaccine
AntibodyOften no specific antibody; some have anti-MOGAQP4-IgG (aquaporin-4)Sometimes anti-MOG
Optic nerve involvementYes, unilateral typicalYes, often bilateral, severeYes, often bilateral
Spinal cord lesionsShort segment (< 2 vertebral segments)Longitudinally extensive (≥ 3 segments)Variable
Brain MRIPeriventricular plaques (Dawson's fingers), juxtacortical, infratentorialOften relatively spared early; periependymal involvementMultifocal large hyperintensities, ALL same age
CSFOligoclonal bands +, ↑ IgG indexOligoclonal bands usually NEGATIVE; AQP4-IgG +Pleocytosis common; oligoclonal bands variable / often transient
Encephalopathy at onsetUncommonUncommonTYPICAL (children with confusion / coma)
Treatment of acute attackHigh-dose IV steroidsHigh-dose IV steroids + plasma exchange; long-term: rituximab, eculizumab, othersHigh-dose IV steroids; IVIG / plasma exchange if severe
Long-term immunotherapyYes — disease-modifying therapies (interferons, glatiramer, fingolimod, ocrelizumab, etc.)Yes — and beware: some MS drugs worsen NMOUsually not needed (monophasic)

The Pivot

Three questions tell you which one:

  1. Course — relapsing or monophasic? Monophasic (and the patient is a child after a viral illness with encephalopathy) → ADEM. Relapsing → MS or NMO.
  2. AQP4-IgG positive? → NMOSD.
  3. Spinal cord lesion length? Longitudinally extensive (≥ 3 segments) → NMO. Short segment → MS.

One trap: starting an MS drug (especially a sphingosine-1-phosphate modulator or some natalizumab patients) in an undiagnosed NMOSD patient can worsen disease.

NBME-Style Stem

A 34-year-old woman presents with simultaneous bilateral visual loss and paraparesis. MRI of the spinal cord shows a longitudinally extensive lesion spanning T2 through T8. Serum aquaporin-4 IgG is positive. CSF shows no oligoclonal bands. Which of the following is the most likely diagnosis?
Concept Anchor
MS is a chronic relapsing T-cell-driven demyelination scattered through the brain and short cord segments; NMO is an AQP4-antibody attack focused on optic nerve and long cord segments; ADEM is a one-off post-infectious storm in a child with encephalopathy. Antibody and lesion length are the two best splitters.

← Bit Library  ·  Log a missed question →